← All stocks

Calidi Biotherapeutics, Inc.

CLDI No buying or selling
CIK 0001855485 #5519 in the set updated 17 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

6 insiders · 0 transactions
0.1×

Eric Poma holds only 0.1 times base salary in stock. $36.38K of shares against $358.04K in salary for 2025.

Salary from the company's own proxy. The shares are what Eric Poma last reported holding, valued at $1.46, the price Common Stock was last bought or sold at on the open market here, on 12 Dec 2025.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Camaisa Allan
Director
143,664
$209.03K
+70.3%
Leftwich Scott
Director
130,650
$190.10K
Schoeneck James A
Director
76,134
$110.77K
+6,614%
Stewart Alan R.
Director
28,976
$42.16K
+78.8%
Poma Eric E
Chief Executive Officer
25,000
$36.38K
Jackson Andrew C.
Chief Financial Officer
2,500
$3.64K

No percentages here. This company's share count has moved by a factor of 11.0 over the window, from 2,584,184 to 28,467,580 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 8
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 0
History held since 14 Sep 2022